News NICE backs Alimera’s three-year uveitis implant An implant developed by Alimera Sciences has been recommended by NICE to treat an inflammatory eye disease that can cau
News Vaccines mistrust a “global crisis” says Wellcome report A wide-ranging survey involving 140,000 people in 140 countries has revealed a worryingly high level of concern about the safety of vaccines, with scepticism highest in the developed world.
News Merck claims a brace of head and neck cancer approvals Merck & Co/MSD has done the double in head and neck cancer with a pair of FDA approvals for Keytruda in newly diagnosed patients on the same day.
News ICER posts damning report on Sarepta’s Duchenne drug Exondys... Controversy has dogged Sarepta’s Duchenne muscular dystrophy therapy Exondys 51 since its approval, and it’s not out of the woods yet.
News FDA overrides adcomm and approves AZ's oral SERD The FDA has gone against the advice of its own expert advisors and approved AstraZeneca's Etcamah as a frontline treatment for breast cancer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
